Explore effective treatment strategies and multidisciplinary approaches for managing chronic graft-versus-host disease post-allogeneic stem cell transplant.
Optimizing Treatment Sequencing in Chronic Graft-versus-Host Disease After Allogenic Transplant
A 52-year-old woman experiences chronic GvHD post-stem cell transplant, showcasing skin and joint symptoms, requiring ongoing steroid management.
A 52-year-old woman experiences chronic GvHD post-stem cell transplant, showcasing complex symptoms and treatment challenges. Discover her journey and management strategies.
Explore the assessment and treatment options for chronic graft versus host disease, focusing on organ involvement and second-line therapies.
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
NCCN Updates Breast Cancer Guidelines: Sacituzumab Govitecan for 1L TNBC
2
FDA Accepts BLA for Ivonescimab in Pretreated EGFR-Mutated NSCLC
3
FDA Grants FTD to GPRC5D Bispecific LBL-034 for R/R Multiple Myeloma
4
Multiomic Real-World Data Predict Outcomes in Metastatic Breast Cancer
5